Medicus AI opens office in China and plans for faster global expansion with €20 million Series B funding round

Medicus AI launches in China with office in Shenzhen after closing its first funding round in the subsidiary totaling €1.2 million led by VC Sunhope

After closing €5 million in Series A funding this year and successfully expanding in China with a seed round of €1.2 million, Medicus AI is excited to announce the launch of its Series B funding round of €20 million, to close in H1 2020.

As Medicus embarks on its next phase, it continues its global expansion into key markets, such as Brazil, Portugal, Japan, Belgium and the Netherlands.

Dr. Baher Al Hakim, CEO, Medicus, said, “This year, in every market we’ve explored from Brazil all the way to Japan and Australia, whether by design or in response to an opportunity, we learned about developing trends and opportunities confirming the faster developing space for our solutions!

We are more confident than ever that this is the right time for Medicus AI to be available in these new markets as well as in markets that we haven’t explored yet. This is driving our decision to grow faster than initially planned.”

Today, Medicus supports both the diagnostic industry as well as the insurance and wellbeing sectors with a range of solutions that deliver medically verified and locally adapted insights in each market, including France, Germany, Luxembourg, Switzerland, and the Middle East, including others.

Medicus is also excited to announce its recent incorporation in China. Marking this entry, Medicus closed the first round of investment in its Chinese subsidiary with a total of €1.2 million, led by Sunhope, a Chinese and international VC, and supported by contributions from historic investors.

Francisco Vega, Head of New Markets, Medicus AI, said, “We have the chance to be supported by long-term investors that trust our capabilities and stand behind our vision, and we are happy to welcome Sunhope among them. With this initial investment in China, we are opening our China office, based in Shenzhen, starting with a core local team of 18 people, and with plans to further expand the team in 2020 to support our aggressive growth strategy.”

Dr. Peng Yuan, Cofounder, Sunhope VC said: “Medicus’ technology delivers value across the entire medical care system, from expanding the reach and access of patients, to improving the efficiency of doctors. After seeing their plans and initial traction in China, we are happy and excited to lead this round and to continue backing their growth towards their full potential in China.”

Officially announced during the D-Day event organized by Ping An Cloud Accelerator in Shenzhen, China, last month, Medicus has already confirmed a number of projects in China, including its flagship project with the largest life insurer in China.

“The projects that we have confirmed in China are some of the most promising in Medicus’ history, and we have been working on other very exciting projects that will be announced very soon. We truly hope that this will inspire more Western businesses to turn their eyes to China,” added Mr. Vega.

About Medicus AI

Medicus is a fast-growing ambitious company committed to bringing health literacy and positive behavioral change to patients and users everywhere by building innovative tech products that transform businesses and improve people’s lives.

Our mission is to contribute to today’s continuously evolving healthcare industry by changing the way doctors and patients think about health. We have an obsessive and meticulous approach to data privacy and protection, believe ardently in the democratization of health data, and place ethical considerations above all else.

We build products that are smart and intuitive, tell a clear story, and are a pleasure and delight to use. We place the patient and user at the center of everything we do and build products that are meaningful and improve the lives and jobs of everyone in the healthcare ecosystem.

About Sunhope VC

SVC is a VC company focusing on early stage technology projects. It was founded in March 2018 with a size of 100 million USD. All the funds used for investment come from the Hong Kong family office. The company is registered in the Cayman Islands and has offices in Hong Kong, Shenzhen and Silicon Valley in the United States. It can help global innovative start-ups connect with the Chinese market.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)